Clear Scientific News

Portland, OR | June 2026 Piercen Oliver PhD, VP of R&D and Xinhua Li PhD, Executive Vice President Drug Development of Clear Scientific Inc. presented at the 88th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD) in Portland, Oregon, June 13th-17th. CPDD provides a national and international forum for scientists of diverse backgrounds to advance the understanding of molecular-neurobiological aspects of addictive disorders and improve and develop

Kiawah Island, SC | June 2026 Peter Howe, CFO, and Shekar Shetty, CEO, from Clear Scientific attended the 2026 Coastal Emergency Medicine Conference (CEMC) June 4th-6th in Kiawah Island, South Carolina. For over a decade, this American College of Emergency Physician (ACEP) chapter has hosted Emergency Physicians from Georgia, South Carolina and North Carolina as well as associated professionals to connect, share practice-changing education, and engage in forward-thinking

Cambridge, MA | April 2026 On April 17, 2026, Piercen Oliver PhD, VP of Research & Development of Clear Scientific Inc. presented at the Inaugural UC Summit on Methamphetamine: Advancing Research, Policy, and Public Health. The UC Summit is committed to being an outstanding beginning to building region wide efforts that address the challenges of intervention on methamphetamine use in Riverside County and throughout California. Dr. Oliver’s talk centered around Treatment Inn

Dubai | February 2026 Clear Scientific, represented by Peter Howe, Co-Founder and CFO participated in the World Health Expo (WHX) Dubai 2026, a global healthcare platform focusing on life sciences innovation in the Middle East North Africa (MENA) region. This conference underscores the growing importance of cross border engagement between the Middle East and the Americas in accelerating life sciences investment, commercialization, and innovation. Clear Scientific participat

Boston, MA | July 2025 On July 31, Winston Henderson, General Counsel at Clear Scientific Inc., joined a panel with Carl Berke (Mass General Brigham Ventures), Michael Freni (AI Digital Innovation Fund), and moderator Sherene Shenouda (Mass General Brigham Innovation) to discuss funding innovation in the Substance Use Disorder (SUD) space. The panel explored how stakeholders—including investors, researchers, hospital leaders, and policymakers—can collaborate to advance and c

New Orleans, Louisiana | June 2025 On June 16, 2025, Piercen Oliver PhD, VP of R&D and Xinhua Li PhD, Executive Vice President Drug Development of Clear Scientific Inc., a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, presented a poster titled Development of CS-1103 a First-in-Class Treatment for Methamphetamine Intoxication at the 87th in New Orleans, LA. The presentation described the chemistry, anticipated benefits, Phase 1 resu

Hamburg, Germany | May 2025 Shekar Shetty, Chief Executive Officer of Clear Scientific Inc., a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, was invited to deliver a keynote address at the inaugural International Society of Addiction Medicine’s (ISAM) Global Addiction Therapeutics Innovation Day event, which was held in Hamburg, Germany, on May 25, 2025. The event comprised a full-day pre-conference session preceding the ISAM 2025 Annual

San Antonio, TX | March 2025 On March 23, 2025, Dr. Xinhua Li, Executive Vice President of Clear Scientific Inc., a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, presented a keynote talk at the 18th Annual Conference in Behavior, Biology, and Chemistry Translational Research in Substance Use Disorders held in San Antonio, Texas. This conference centers on the translational aspects of substance use disorder research among chemists, biolog

Rockville MD | Dec 2024 On December 17-18, 2024, Dr. Xinhua Li and Dr. Mitch Zakin of Clear Scientific Inc., a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, presented a poster titled “A Broad-Spectrum Therapeutic as a Countermeasure Against Acute Opioid and Polydrug Intoxication” at the Advances in Developing Medical Countermeasures Against Opioids and Drug-Induced Respiratory Depression Conference in Rockville, Maryland. The growing public heal

Las Vegas, NV | Oct 2024 Peter Howe and Charlotte Leggett from Clear Scientific attended the 2024 American College of Emergency Physicians (ACEP) Scientific Assembly in Las Vegas, Nevada. The conference hosts an environment for physicians to connect, share practice-changing education, and engage in forward-thinking collaboration. Through physician conversation, it is clear that methamphetamine intoxication has high prevalence across a variety of United States regions. Some

Roanoke, WV | Sept 2024 On September 19th, Winston Henderson, VP, General Counsel, Peter Howe, CFO, and Charlotte Leggett, Scientific Liaison, of Clear Scientific, Inc. attended the annual meeting of the WVACEP, the West Virginia Chapter of the American College of Emergency Physicians, in Roanoke, WV. West Virginia has been heavily impacted by the overdose epidemic and is the U.S. state with the highest number of overdose deaths involving methamphetamine per capita (Center o

Montreal, Canada | June, 2024 Dr. Xinhua Li, Executive Vice President of Drug Development at Clear Scientific Inc, a Cambridge, MA biotech, presented a talk titled: A Novel Approach to Treat Xylazine and Opioid Intoxication at the 86th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD). The presentation outlined Clear Scientific’s approach using a novel sequestrant CS-1103 to treat intoxication from combinations of fentanyl and xylazine. The immed

Atlanta, GA | April 1, 2024 Clear Scientific presented a poster titled: Hope in Methamphetamine Addiction and Overdose, Authors: P. Oliver, C. Leggett, M. Vara, A. Mager, X. Li, M. Zakin, S. Shetty, at the 2024 Rx and Illicit Drug Summit (https://www.hmpglobalevents.com/rx-summit). The poster outlined CS Inc.’s approach using a novel sequestrant CS-1103 to treat methamphetamine use disorder, particularly overdose. The immediate sequestration of methamphetamine leads to rapid

Boston, MA | August 2023 On August 17th 2023 Winston Henderson, General Counsel of Clear Scientific Inc., participated as a panelist in L-SPRINT, a program sponsored by the National Institute on Drug Abuse (NIDA) and Babson College in Boston, MA. L-SPRINT’s purpose is to provide early-stage substance use disorder (SUD) researchers with the skills and knowledge they need to launch and run successful biotech and pharmaceutical companies. The program aims to promote entrepreneu

Denver, CO | June 2023 Clear Scientific presented a poster titled: A Novel Approach to Treat Fentanyl Intoxication, Authors: X. Li, P. Oliver, M. Vara, C. Leggett, S. Shetty, M. Zakin, at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD). The poster outlined CS Inc.’s approach using a novel sequestrant CS-1103 to treat fentanyl intoxication. The immediate sequestration of fentanyl leads to rapid draining of fentanyl from the brain resto

Cambridge, MA | May 2023 Shekar Shetty, CEO and Dr. Piercen Oliver, VP R&D of Clear Scientific presented at the Charles River Sixth Annual World Congress, a global event. The conference is an ongoing effort to progress and raise awareness to how advanced modalities are disrupting drug development. This event showcased how advanced modalities are shaping drug development through presentations from biopharmaceutical companies, academia, panel discussions, investors, and patie

Minneapolis, MN | June 2022 Clear Scientific’s Executive VP Chemistry, Xinhua Li PhD, presented progress on CS-1103, a first-in-class therapeutic for treatment of acute methamphetamine intoxication, at the College on Problems of Drug Dependence (CPDD) 84th Annual Scientific Meeting in Minneapolis MN on June 13, 2022. CPDD has been in existence since 1929. The organization serves as an interface among government, industry, regulatory, treatment, prevention, and academic commun

Boston, Massachusetts | August 2021 Clear Scientific’s Chief Scientific Officer, Mitchell Zakin PhD, Executive VP Chemistry, Xinhua Li PhD, and Medical Director, John Marota MD, PhD, presented progress on CS-1103, a first-in-class therapeutic for treatment of acute methamphetamine intoxication, at the 6th Annual Chemistry and Pharmacology of Drug Abuse Conference (CPDA). This event, held in Boston, MA on August 6th and 7th, 2021, brings together leading medicinal chemists, p

Rockville, Maryland | August 2019 The Executive Vice President of Chemistry for Clear Scientific, Xinhua Li, Ph.D., presented at the Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression at the NIAID Conference Center in Rockville, MD. The event was sponsored by the Chemical Countermeasures Research Program, which integrates cutting edge research with the latest technological advances in science and medicine to